Gulf Pharmaceutical Industries Julphar Announces Q1 2022 Results; Delivers Robust Top and Bottom-Lin ...
• Q1 2022 Net sales from continuing operations were AED 418.6 m, a 156% increase from Q1 2021
• Q1 2022 EBITDA from continuing operations reached AED 40m, compared to AED 0.2m in Q1 2021
• Company recently announced 2030 growth strategy
May 17, 2022, Ras Al Khaimah, UAE: Gulf Pharmaceutical Industries PSC ......Read More